The Trump administration is closing a loophole that drugmakers could use to avoid negotiations when they add active ...
The cost of drugs to payers and consumers is a staple hot button in the American political landscape. Despite ample evidence as to what has worked and what doesn’t, changes in drug pricing policy have ...
There is broad, bipartisan agreement that there should be more government regulation when it comes to prescription drug costs, according to KFF, a nonprofit health policy research, polling, and news ...
The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...
The authors write "The Food, Drug and Cosmetic Law Section of the New York State Bar Association is delving into the changing face of health law and regulations as part of its Annual Meeting taking ...
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and "unleash AI." This story is part of MIT Technology Review’s "America Undone” ...
A loophole in prescription drug regulation exposes American consumers to false and misleading claims of drug ads via on-line businesses promoting potent drugs without accurate information about their ...
WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 ...
The Food and Drug Administration (FDA) is a federal regulatory agency that has left a tangible mark on American life. Through a long, controversial, but often distinguished history y the agency has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results